(Q41113324)

26 September 2017

Characterization of the binding and activity of a high affinity, pseudoirreversible morpholino tachykinin NK1 receptor antagonist (English)

1 reference

26 September 2017

0 references

Cascieri MA

1

1 reference

26 September 2017

Ber E

2

1 reference

26 September 2017

Fong TM

3

1 reference

26 September 2017

Hale JJ

4

1 reference

26 September 2017

Tang F

5

1 reference

26 September 2017

Shiao LL

6

1 reference

26 September 2017

Mills SG

7

1 reference

26 September 2017

MacCoss M

8

1 reference

26 September 2017

Sadowski S

9

1 reference

26 September 2017

Tota MR

10

1 reference

26 September 2017

Strader CD

11

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

European Journal of Pharmacology

26 September 2017

1 reference

26 September 2017

325

1 reference

26 September 2017

2-3

1 reference

26 September 2017

253-261

1 reference

Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900122-2

Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900122-2

Molecular characterization of a common binding site for small molecules within the transmembrane domain of G-protein coupled receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900122-2

Direct evidence that capsaicin-induced plasma protein extravasation is mediated through tachykinin NK1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900122-2

Amino-aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900122-2

2(S)-((3,5-bis(trifluoromethyl)benzyl)-oxy)-3(S)-phenyl-4- ((3-oxo-1,2,4-triazol-5-yl)methyl)morpholine (1): a potent, orally active, morpholine-based human neurokinin-1 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900122-2

N-heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900122-2

Effect of RP 67580, a non-peptide neurokinin1 receptor antagonist, on facilitation of a nociceptive spinal flexion reflex in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900122-2

Expression and solubilization of a recombinant human neurokinin-1 receptor in insect cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900122-2

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900122-2

Antiinflammatory and analgesic activity of a non-peptide substance P receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900122-2

Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900122-2

Mutations in transmembrane segment VII of the AT1 receptor differentiate between closely related insurmountable and competitive angiotensin antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900122-2

A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900122-2

Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900122-2

10.1016/S0014-2999(97)00122-2

7 January 2021

Identifiers

DOI

1 reference

26 September 2017

1 reference